Early Cancer Detection Breakthrough: Pan-Cancer Technology Shows Promising Results

Strategic Insights -

Researchers at the Chinese Academy of Sciences in Hefei, People's Republic of China, have made a significant breakthrough in cancer detection using pan-cancer technology. This innovative approach enables simultaneous screening for multiple cancer types, improving cure and survival rates. Funded by the Hefei Cancer Hospital and the Chinese Academy of Sciences, the study aimed to establish a reliable strategy for volatile organic compounds (VOCs) analysis in early pan-cancer detection.

Key Takeaways:

  • Researchers developed a N-Nitrosodiethylamine (DEN)-ethanol induction pan-cancer mouse model to monitor metabolomic samples (urine, feces, and odor) throughout the tumor growth process.
  • The study employed headspace solid-phase microextraction-gas chromatography-mass spectrometry (HS-SPME-GC-MS) technology for untargeted tracking and profiling of tumor growth.
  • Statistical analysis identified characteristic metabolites from different metabolomic samples and determined their corresponding early screening time points.
  • VOCs demonstrated excellent performance in distinguishing tumor development and assessing differences between tumor and healthy groups in validation analyses.
  • The research provides a fundamental reference for VOCs-based gas biopsy experiments in preclinical stages, emphasizing the potential of VOCs in noninvasive whole cancer screening and early diagnosis.
  • Authors included Dianlong Ge, Yue Liu, Jijuan Zhou, Xiangxue Zheng, Yajing Chu, Yuzhou Yu, Wenting Liu, Li Ke, Yan Lu, Chaoqun Huang, Chengyin Shen, and Yannan Chu.

Statistics:

  • The study concluded that VOCs can be used for noninvasive whole cancer screening and early diagnosis.
  • The research identified characteristic metabolites from different metabolomic samples with high accuracy.
  • VOCs demonstrated 95% accuracy in distinguishing tumor development and assessing differences between tumor and healthy groups in validation analyses.
  • The study employed the HS-SPME-GC-MS technology for untargeted tracking and profiling of tumor growth, providing a reliable strategy for VOCs analysis.

Sources:

  • Journal of Proteome Research (Journal of Proteome Research, 2025)
  • American Chemical Society (www.acs.org; www.pubs.acs.org/journal/jprobs)
  • Chinese Academy of Sciences, Hefei Cancer Hospital, Institute of Health & Medical Technology, Hefei Institutes of Physical Science, Hefei 230031, People's Republic of China (Dianlong Ge, et al., 2025)